University of Maryland BioPark Attracts Two New Internationally Focused Commercial Tenants

BOSTON, June 19, 2012 /PRNewswire/ -- The University of Maryland BioPark announced today from the BIO International Convention that two internationally focused life science companies ­– Biogen Diagnostics Ltd. and Global Scientific Solutions for Health Inc. (GSSHealth) – have signed leases and joined the growing community of commercial tenants at the BioPark.

"We are pleased to welcome two additional impressive life science tenants to the BioPark," said James L. Hughes, University of Maryland Research Park Corporation President. "Having two companies with international operations select the BioPark as a primary U.S. location clearly demonstrates the tremendous growth potential for companies locating on our academic medical center campus."

A United Kingdom-based company, Biogen Diagnostics plays a pioneering role in personalized healthcare and is providing the first molecular diagnostics products that are tailored to the needs of specific patient groups. GSSHealth is a USWCC-certified Woman-Owned Small Business that has been supporting the establishment of quality-assured laboratory testing for cross-continental public health programs and clinical research studies since 2008. GSSHealth currently works in six countries across South East Asia (Burma, Cambodia, China, Lao PDR, Thailand and Vietnam) and supports projects in Rwanda and a project in Ethiopia that impacts the African continent as a whole.

About the University of Maryland BioPark

The UM BioPark is a biomedical research park on the campus of the University of Maryland, Baltimore. The BioPark welcomes additional life science companies to join its growing scientific community of emerging, high-growth life science tenants and University of Maryland (UM) translational research centers. For early-stage to mature bioscience companies, the BioPark offers a sophisticated laboratory and office environment on the UM's vibrant academic medical center campus. Community members are commercializing new drugs, diagnostics and devices and advancing biomedical research. Learn more about our tenants at http://www.umbiopark.com/tenants.aspx.

SOURCE University of Maryland BioPark

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED